Mitral Regurgitation Functional clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Early Feasibility Study (EFS) of the Nyra Cardiac Leaflet Enhancer (CARLEN) System
open to eligible people ages 21 years and up
Safety and performance evaluation of the CARLEN System in patients with functional mitral valve regurgitation.
at UC Davis
Last updated: